Equity Profile

ABT

Abbott Laboratories

Health CareHealth Care Equipment$192.5B

Jul16Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Abbott Laboratories (ABT) is a global health care company that develops and manufactures a wide range of medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals. With a market cap of $193 billion, Abbott plays a crucial role in the health care sector, focusing on innovation and improving patient outcomes.

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of profitability and will show how well Abbott is managing its costs and revenue.

$1.28

Revenue

Total revenue provides insight into the overall sales performance and demand for Abbott's products.

$12.5B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ABT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+1.05%

Avg Stock Reaction

-3.34%

Last Quarter Recap

In Q1-2026, Abbott reported an EPS of $1.15, slightly beating estimates. However, the stock dropped 6% the following day, indicating market disappointment despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Abbott to report steady earnings and revenue growth this quarter, with a consensus EPS of $1.28 and revenue of $12.5 billion. Investors are closely watching for any signs of growth in key product lines.

Bull Case

If Abbott can exceed EPS expectations and demonstrate strong revenue growth, it could signal robust demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if Abbott fails to meet earnings expectations or shows signs of declining sales, it could lead to further stock price declines, especially given the recent performance.

Key Metrics to Watch

EPS

$1.28

Earnings per share (EPS) is a key indicator of profitability and will show how well Abbott is managing its costs and revenue.

Revenue

$12.5B

Total revenue provides insight into the overall sales performance and demand for Abbott's products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Abbott's EPS exceed the consensus estimate of $1.28?

A beat on EPS could indicate strong operational performance and boost investor confidence.

What are the revenue figures for Abbott's key product segments?

Understanding revenue performance in key areas will help gauge overall business health and future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Abbott's ability to leverage new product launches, which could drive higher-than-expected revenue growth this quarter.

Supporting Evidence

Abbott's recent product innovations have not been fully reflected in analyst estimates.

The options market is pricing for a larger move than historical averages suggest, indicating potential surprises.

Recent insider buying suggests confidence in Abbott's future performance.

Key Risk

If Abbott's new product lines show stronger sales than anticipated, it could significantly alter revenue expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on Abbott's ability to maintain profitability and revenue growth amid market challenges.

Bull Confirmed If

An EPS of $1.30 or higher would confirm the bull case and suggest strong demand for Abbott's products.

Bear Confirmed If

An EPS below $1.26 would support the bear case, indicating potential struggles in revenue generation.

Pre-Earnings Positioning

Options Market

Implied Move

±8.67%

Historical Avg

±4.6%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±8.7% while ABT has averaged ±4.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

26.1%

Calls (760K)P/C Ratio: 0.51Puts (2.8M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Abbott beats expectations, history suggests the stock could rise by around 4.62% on the first day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.

Miss

A miss on earnings could lead to a decline in stock price, with historical data indicating an average drop of around 3.34% following such events.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

R-GARichard Dean Dr McCormickRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on sales performance for Abbott's new product launches.
2Any commentary on cost management and operational efficiency.
3Insights into market demand trends in key segments.
4Management's outlook for the remainder of the fiscal year.
5Details on any regulatory changes affecting Abbott's product lines.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Fastenal Company

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of profitability and will show how well Abbott is managing its costs and revenue.

$1.28

Revenue

Total revenue provides insight into the overall sales performance and demand for Abbott's products.

$12.5B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ABT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+1.05%

Avg Stock Reaction

-3.34%

Last Quarter Recap

In Q1-2026, Abbott reported an EPS of $1.15, slightly beating estimates. However, the stock dropped 6% the following day, indicating market disappointment despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Abbott can exceed EPS expectations and demonstrate strong revenue growth, it could signal robust demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if Abbott fails to meet earnings expectations or shows signs of declining sales, it could lead to further stock price declines, especially given the recent performance.

Key Metrics to Watch

EPS

$1.28

Earnings per share (EPS) is a key indicator of profitability and will show how well Abbott is managing its costs and revenue.

Revenue

$12.5B

Total revenue provides insight into the overall sales performance and demand for Abbott's products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Abbott's EPS exceed the consensus estimate of $1.28?

A beat on EPS could indicate strong operational performance and boost investor confidence.

What are the revenue figures for Abbott's key product segments?

Understanding revenue performance in key areas will help gauge overall business health and future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Abbott's ability to leverage new product launches, which could drive higher-than-expected revenue growth this quarter.

Supporting Evidence

Abbott's recent product innovations have not been fully reflected in analyst estimates.

The options market is pricing for a larger move than historical averages suggest, indicating potential surprises.

Recent insider buying suggests confidence in Abbott's future performance.

Key Risk

If Abbott's new product lines show stronger sales than anticipated, it could significantly alter revenue expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on Abbott's ability to maintain profitability and revenue growth amid market challenges.

Bull Confirmed If

An EPS of $1.30 or higher would confirm the bull case and suggest strong demand for Abbott's products.

Bear Confirmed If

An EPS below $1.26 would support the bear case, indicating potential struggles in revenue generation.

Pre-Earnings Positioning

Options Market

Implied Move

±8.67%

Historical Avg

±4.6%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±8.7% while ABT has averaged ±4.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

26.1%

Calls (760K)P/C Ratio: 0.51Puts (2.8M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Abbott beats expectations, history suggests the stock could rise by around 4.62% on the first day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.

Miss

A miss on earnings could lead to a decline in stock price, with historical data indicating an average drop of around 3.34% following such events.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

R-GARichard Dean Dr McCormickRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on sales performance for Abbott's new product launches.
2Any commentary on cost management and operational efficiency.
3Insights into market demand trends in key segments.
4Management's outlook for the remainder of the fiscal year.
5Details on any regulatory changes affecting Abbott's product lines.